Cognex Corporation (NASDAQ:CGNX) shares fell to a low of $73.42 before closing at $73.45. Intraday shares traded counted 0.78 million, which was 4.6% higher than its 30-day average trading volume of 821.49K. CGNX’s previous close was $74.11 while the outstanding shares total 176.29M. The firm has a beta of 1.66, a 12-month trailing P/E ratio of 58.06, and a growth ratio of 3.87. The stock’s Relative Strength Index (RSI) is 28.91, with weekly volatility at 2.51% and ATR at 2.13. The CGNX stock’s 52-week price range has touched low of $52.24 and a $101.82 high. The stock traded lower over the last trading session, losing -0.89% on 05/18/21.
Investors have identified the Scientific & Technical Instruments company Cognex Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $12.82 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Cognex Corporation (CGNX) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 625.57 million total, with 159.68 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 1.64 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CGNX sounds very interesting.
Is the stock of CGNX attractive?
In related news, Director, Schneider Jerry A. sold 5,000 shares of the company’s stock in a transaction that recorded on Mar 18. The sale was performed at an average price of 82.26, for a total value of 411,292. As the sale deal closes, the EVP, Vision & ID Products, Gerst Carl now sold 115,000 shares of the company’s stock, valued at 9,517,136. Also, Director, PARROTTE DIANNE M sold 9,800 shares of the company’s stock in a deal that was recorded on Feb 19. The shares were price at an average price of 87.06 per share, with a total market value of 853,226. Following this completion of acquisition, the Director, ALIAS PATRICK now holds 20,000 shares of the company’s stock, valued at 1,847,516. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
4 out of 19 analysts covering the stock have rated it a Buy, while 10 have maintained a Hold recommendation on Cognex Corporation. 4 analysts has assigned a Sell rating on the CGNX stock. The 12-month mean consensus price target for the company’s shares has been set at $90.00.